Pharmaceutical Products (Exemestane, Film-Coated Tablets, 25 Mg Each In A Blister, Tamoxifen, Tablets, 20 Mg Each, Letrozole Film-Coated Tablets, 2.5 Mg Each, Anastrozole Film-Coated Tablets 1 Mg Each, Dapagliflozin Film-Coated Tablets Shell, 10 Mg Each, Paracetamol Tablets/Capsules 500 Mg Each, Ibuprofen Tablets/Capsules 400 Mg Each, Ibuprofen Oral Suspension 200 Mg/5 Ml 100 Ml, Ibuprofen Oral Suspension 100 Mg/5 Ml, 100 Ml Each, Albendazole Tablets 400 Mg Each, Pancreatin, Lipolytic Units: 25,000, Pancreatin, Lipolytic Units: 10,000, Dexamethasone, Solution For Injection 4 Mg/Ml, Acetazolamide, Tablets, 250 Mg Each)

НЕКОМЕРЦІЙНЕ КОМУНАЛЬНЕ ПІДПРИЄМСТВО ЮЖНОУКРАЇНСЬКИЙ МІСЬКИЙ ЦЕНТР ПЕРВИННОЇ МЕДИКО-САНІТАРНОЇ ДОПОМОГИ Ukraine has Released a tender for Pharmaceutical Products (Exemestane, Film-Coated Tablets, 25 Mg Each In A Blister, Tamoxifen, Tablets, 20 Mg Each, Letrozole Film-Coated Tablets, 2.5 Mg Each, Anastrozole Film-Coated Tablets 1 Mg Each, Dapagliflozin Film-Coated Tablets Shell, 10 Mg Each, Paracetamol Tablets/Capsules 500 Mg Each, Ibuprofen Tablets/Capsules 400 Mg Each, Ibuprofen Oral Suspension 200 Mg/5 Ml 100 Ml, Ibuprofen Oral Suspension 100 Mg/5 Ml, 100 Ml Each, Albendazole Tablets 400 Mg Each, Pancreatin, Lipolytic Units: 25,000, Pancreatin, Lipolytic Units: 10,000, Dexamethasone, Solution For Injection 4 Mg/Ml, Acetazolamide, Tablets, 250 Mg Each) in Pharmaceuticals. The tender was released on Aug 12, 2024.

Country - Ukraine

Summary - Pharmaceutical Products (Exemestane, Film-Coated Tablets, 25 Mg Each In A Blister, Tamoxifen, Tablets, 20 Mg Each, Letrozole Film-Coated Tablets, 2.5 Mg Each, Anastrozole Film-Coated Tablets 1 Mg Each, Dapagliflozin Film-Coated Tablets Shell, 10 Mg Each, Paracetamol Tablets/Capsules 500 Mg Each, Ibuprofen Tablets/Capsules 400 Mg Each, Ibuprofen Oral Suspension 200 Mg/5 Ml 100 Ml, Ibuprofen Oral Suspension 100 Mg/5 Ml, 100 Ml Each, Albendazole Tablets 400 Mg Each, Pancreatin, Lipolytic Units: 25,000, Pancreatin, Lipolytic Units: 10,000, Dexamethasone, Solution For Injection 4 Mg/Ml, Acetazolamide, Tablets, 250 Mg Each)

Deadline - Aug 12, 2025

GT reference number - 90724586

Product classification - Pharmaceutical products